MedTrace Logo

Prediction of Multidrug-resistant Bacterial Infection in Patients with Cirrhosis

NCT05641025 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1774

Last updated 2025-03-14

No results posted yet for this study

Summary

The aim of this study is to identify predictive factors of infections caused by multidrug-resistant organisms in patients with cirrhosis and to develop and validate (internally and externally) a predictive model that might be useful to use in clinical settings to stratify the risk and lead clinical decision-making strategies.

Conditions

Sponsors & Collaborators

  • International Club of Ascites

    collaborator UNKNOWN

  • Hospital Italiano de Buenos Aires

    lead OTHER

Principal Investigators

  • Sebastián Marciano, MD, MsC · Hospital Italiano de Buenos Aires, Argentina

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-16
Primary Completion
2022-12-30
Completion
2023-01-30

Countries

  • Argentina

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05641025 on ClinicalTrials.gov